<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-------------
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
Virologix Corporation
--------------------------------------------------------------
(Exact Name of Registrant as Specified in its Charter)
Delaware 13-3864869
- --------------------------------------------------------------------------------
(State of Incorporation or Organization) (I.R.S. Employer Identification No.)
666 Third Avenue, 30th Floor
New York, NY 10017
- ------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
Securities to be registered pursuant to Section 12(b) of the Act:
Title of Each Class Name of Each Exchange on Which
to be so Registered Each Class is to be Registered
--------------------------------------------------------------------------
None.
If this form relates to the registration of a class of debt securities and
is effective upon filing pursuant to General Instruction A.(c)(1), please check
the following box. [ ]
If this form relates to the registration of a class of debt securities and
is to become effective simultaneously with the effectiveness of a concurrent
registration statement under the Securities Act of 1933 pursuant to General
Instruction A.(c)(2), please check the following box. [ ]
Securities to be registered pursuant to Section 12(g) of the Act:
Common Stock (par value $0.0001 per share)
-------------------------------------------------------------
(Title of Class)
<PAGE>
Item 1. Description of Registrant's Securities to be Registered.
Information concerning the Common Stock, par value $0.0001 per share, of
Virologix Corporation (the "Company"), to be registered hereunder is
incorporated by reference to the section entitled "Description of Securities" in
the prospectus forming a part of the Registration Statement on Form SB-2, as
amended (Registration No. 333-16677), filed by the Company under the Securities
Act of 1933, as amended.
Item 2. Exhibits.
1. The Company's Registration Statement on Form SB-2, as amended (Registration
No. 333-16677), is incorporated herein by this reference.
2. The Certificate of Incorporation of the Company is incorporated herein by
this reference to Exhibit 3(a) to the Company's Registration Statement on Form
SB-2, as amended (Registration No. 333-16677).
3. The Bylaws of the Company are incorporated herein by this reference to
Exhibit 3(b) to the Company's Registration Statement on Form SB-2, as amended
(Registration No. 333-16677).
4. A specimen certificate of the Common Stock of the Company is incorporated
herein by this reference to Exhibit 4(a) to the Company's Registration Statement
on Form SB-2, as amended (Registration No. 333-16677).
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of
1934, the registrant has duly caused this registration statement to be signed on
its behalf by the undersigned, thereto duly authorized.
VIROLOGIX CORPORATION
Date: March 24, 1997
By: /s/ Peter V. Golikov
----------------------------------------
Peter V. Golikov
President
